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The R2TP/Prefoldin-like co-chaperone, in concert with HSP90, facilitates assembly
and cellular stability of RNA polymerase II, and complexes of PI3-kinase-like kinases
such as mTOR. However, the mechanism by which this occurs is poorly understood.
Here we use cryo-EM and biochemical studies on the human R2TP core
(RUVBL1–RUVBL2–RPAP3–PIH1D1) which reveal the distinctive role of RPAP3, distinguishing
metazoan R2TP from the smaller yeast equivalent. RPAP3 spans both faces of a single RUVBL
ring, providing an extended scaffold that recruits clients and provides a ﬂexible tether for
HSP90. A 3.6 Å cryo-EM structure reveals direct interaction of a C-terminal domain of RPAP3
and the ATPase domain of RUVBL2, necessary for human R2TP assembly but absent from
yeast. The mobile TPR domains of RPAP3 map to the opposite face of the ring, associating
with PIH1D1, which mediates client protein recruitment. Thus, RPAP3 provides a ﬂexible
platform for bringing HSP90 into proximity with diverse client proteins.
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The R2TP/Prefoldin-like (R2TP/PFDL) complex collabo-rates with the HSP90 molecular chaperone to facilitateassembly, activation, and cellular stability of a range of
multiprotein complexes, including RNA polymerase II (Pol II),
complexes of PI3 kinase-like kinases (PIKKs) such as TOR
and SMG1, and small nuclear ribonuclear protein (snRNPs)
complexes, amongst others1–7. Yeast R2TP complexes comprise
four subunits, RuvB-like AAA+ ATPases Rvb1p and Rvb2p, a
TPR domain-containing protein Tah1p, and a PIH domain
protein Pih1p. Metazoan R2TP complexes contain the ortholo-
gous proteins RUVBL1, RUVBL2, RPAP3, and PIH1D1, respec-
tively. However, whereas the TPR domain-containing component
of the yeast R2TP complex is a small (12 kDa) protein, Tah1p, in
human R2TP this is a large (75 kDa) multi-domain protein,
RPAP3 (RNA polymerase II associated protein 3) (or hSPAGH),
containing two TPR domains. The C-terminal region in RPAP3
has been annotated as a protein domain (pfam13877), which is
also present in other proteins, such as CCDC1038, a dynein arm
assembly factor that interacts with RUVBL29.
In mammals, the R2TP core components associate with
additional subunits of the prefoldin (PFDL) module, forming the
R2TP/PFDL complex. This PFDL module includes prefoldin and
prefoldin-like proteins PFDN2, PFDN6, URI1, UXT, PDRG1,
and it associates with two additional components, the RNA
polymerase subunit POLR2E/RPB5 and WDR92/Monad5,10. In
addition, R2TP/PFDL interacts with additional proteins that serve
as adaptors between R2TP/PFDL and the clients (see later)5,11,12.
RPAP3 was ﬁrst identiﬁed and named after a systematic ana-
lysis of complexes containing components of the transcription
and RNA processing machineries using protein afﬁnity puriﬁca-
tion coupled to mass spectrometry13. RPAP3 was then found to
be a component of the multi-subunit R2TP/PFDL complex14.
Subsequently it was found to associate with Pol II subunits and
HSP90 when Pol II assembly is blocked by α-amanitin, impli-
cating both RPAP3 and HSP90 in Pol II assembly in the cyto-
plasm10. Pol II subunits RPB1, RPB2, and RPB5 all co-precipitate
with RPAP3, but RPAP3 seems to associate independently with
RPB1 and RPB5-containing complexes, suggesting the existence
of different RPAP3 complexes as intermediates in Pol II assembly.
RPAP3 also binds some subunits of RNA Pol I and it may
therefore play a more general role in the assembly of all RNA
polymerases10. The mechanistic details of how RNA Pol II
subunits are recruited to R2TP and how R2TP and HSP90 con-
tribute to Pol II assembly are poorly understood. Unconventional
prefoldin RPB5 Interactor 1 (URI1) interacts with the RPB5/
POLR2E subunit of Pol II, and this suggests that the PFDL
module contributes to recruit Pol II assembly intermediates to the
R2TP/PFLD complex10,15.
Recruitment of PIKK proteins to R2TP is mediated by the
phosphopeptide-binding PIH domain at the N-terminus of
Pih1p/PIH1D1, which recognizes a speciﬁc phosphorylated acidic
motif, generated by casein kinase 2 (CK2)2–4. This motif is
conserved in Tel2p/TELO2, a component of the TTT (Tel2p/
TELO2–Tti1p/TTI1–Tti2p/TTI2) complex that also interacts
directly with PIKKs, thereby bridging their interaction to R2TP.
A similar PIH-binding motif is also found in Mre11p/MRE11A
suggesting that R2TP may also play a role in the assembly of
MRN complexes involved in DNA double-strand break repair2.
Neither Pol II nor snRNPs subunits contain this motif, and must
therefore be recruited to R2TP through alternative mechanisms.
Biogenesis of box C/D snoRNP requires R2TP and additional
factors such as NUFIP1 and the Zinc-ﬁnger HIT domain proteins
ZNHIT3 and ZNHIT6, which have been proposed to function as
adaptors between R2TP and C/D core proteins12. Interestingly,
ZNHIT2, another protein of the same family, was recently shown
to bind RUVBL2 and regulate assembly of U5 small
ribonucleoprotein5. ZNHIT2 may function as a bridging factor
between the U5 snRNP and the R2TP/PFDL, a function where
the Ecdysoneless (ECD) protein could also contribute5,16. Human
ECD homolog interacts with the pre-mRNA-processing-splicing
factor 8 (PRPF8)17, and the R2TP18. Phosphorylated ECD
interacts with the PIH1D1 subunit, as well as with RUVBL1 in a
phosphorylation-independent manner18. Therefore, it seems that
sets of different adaptors collaborate to bring speciﬁc clients to
R2TP/PFLD.
Previous structural and biochemical studies have deﬁned most
of the pairwise interactions of R2TP core components. The TPR
domain of yeast Tah1p mediates interaction with the conserved
MEEVD C-terminal tail peptide of HSP902,19–22, while its
C-terminal extension couples Tah1p to the CS-domain of
Pih1p2,21. The central region of Pih1p mediates recruitment of
Pih1p–Tah1p to the Rvb1p–Rvb2p heterohexameric ring23,24.
The N-terminal PIH domain of Pih1p/PIH1D1 binds a CK2-
phosphorylation motif on Tel2p/TELO2, mediating recruitment
of the TTT complex to R2TP2,3. Most recently, we have deter-
mined the cryo-EM structure of the intact yeast R2TP complex, in
which a single Tah1p–Pih1p sub-complex binds a hetero-
hexameric Rvb1–Rvb2 ring24, a ﬁnding subsequently conﬁrmed
by others25. In metazoan R2TP, the small (12 kDa) single-TPR
domain protein Tah1p is replaced by the much larger (75 kDa)
RPAP3/hSpagh whose N-terminal half contains a tandem pair of
TPR domains that bind in concert to a single HSP90 dimer2.
However, the function of the rest of RPAP3 is unknown. To our
knowledge, the subunit stoichiometry and the structural organi-
zation of a metazoan R2TP complex have not been determined.
To gain further insight into how R2TP/PFDL functions in the
assembly, activation and stabilization of its ‘client’ systems, we
have determined the cryo-EM structure of human R2TP core
complex. Our data reveal a substantially elaborated architecture
compared with the yeast system, in which RPAP3 rather than
PIH1D1 plays the central organizational role, incorporating
additional domains and functions to address the assembly of a
variety of large complexes. We identify the C-terminal domain in
RPAP3 as a helical bundle that binds selectively to the ATPase
domain of RUVBL2. As well as scaffolding the interaction of
PIH1D1 with the RUVBL1–RUVBL2 ring, RPAP3 provides a
ﬂexible tether for HSP90, allowing it to interact with a highly
diverse set of client proteins and complexes.
Results
Recruitment of R2TP components by RPAP3. The human TPR
domain protein RPAP3 is roughly six times larger than its yeast
equivalent Tah1p, and we sought to determine whether it may
provide docking sites for other components of the human R2TP
complex (Fig. 1a). Yeast Pih1p constructs containing the C-terminal
CS domain, and the isolated CS domain itself, are unstable in iso-
lation, but are stabilized by interaction with the C-terminal tail of
Tah126. We found that human PIH1D1 protein was also unstable
when expressed in isolation, and we used this property to identify a
minimal PIH1D1 binding motif in RPAP3 by co-expressing
PIH1D1 with GST-tagged RPAP3 constructs and looking for co-
puriﬁcation of PIH1D1 in GST pull-downs from cell lysates. As well
as in the full-length GST-RPAP3, we found that constructs that
contained residues 400–420 of RPAP3, immediately downstream of
the second RPAP3 TPR domain, were able to form a stable and
soluble complex with full-length PIH1D1 or its isolated CS domain,
when co-expressed (Fig. 1b). PIH1D1-CS was not co-puriﬁed when
co-expressed with a GST-RPAP3 construct lacking residues
400–420 (Fig. 1c). We conclude that residues 400–420 of RPAP3
and the CS domain of PIH1D1 are together both necessary and
sufﬁcient to mediate the interaction of the two proteins.
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We found that full-length RPAP3 protein in the absence of
PIH1D1 was fully competent to bind to the assembled
RUVBL1–RUVBL2 heterohexamer but it binds RUVBL2 and
not RUVBL1 when they are not forming a complex, suggesting
that it is RUVBL2 that mediates most of the interactions to
recruit RPAP3 (Fig. 1d). Dissection analysis of RPAP3 identiﬁed a
segment of the polypeptide between Valine 541 and Glycine 665
as necessary and sufﬁcient to bind RUVBL2 (hereinafter referred
to as RBD, RUVBL2-Binding Domain). The RPAP3–RBD was
also able to pull-down an RUVBL2 construct lacking the DII
‘insertion’ domain (RUVBL2-ΔDII), suggesting the RPAP3–RBD
domain interacts with the ATPase domain face of RUVBL2 rather
than the DII domain face implicated in dodecamer formation
(Fig. 1d). The RBD is the only domain essential to maintain
the RPAP3–RUVBL2 interaction, since an RPAP3–PIH1D1
complex where the RBD is truncated did not bind RUVBL2
(Supplementary Fig. 1). An N-terminal 3xMyc tag in RUVBL1
was used to allow RUVBL1 and RUVBL2 to be discriminated in
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Fig. 1Mapping the interactions in human R2TP core components. a A cartoon for sequence and domains of the components of the human R2TP complex. b
GST pull-down experiments depicting the interactions between the several regions in RPAP3 and PIH1D1. FL stands for full length, CS for the CS domain in
PIH1D1, and MW for molecular weight markers. Be aware that for simpliﬁcation, several PIH1D1 and RPAP3 constructs are indicated within the same lines
on top of the gel. Some minor contaminants are present in some of the samples. c Pull-down experiments showing that removal of residues 401–420 from
an RPAP3 construct eliminates the interaction with the CS domain in PIH1D1. d Pull-down experiments demonstrating the interaction of RPAP3–RBD with
RUVBL2. This interaction is not affected when the DII domains in RUVBL2 are removed
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sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The N-terminal end of RUVBLs locates at the DII
domain face, and thus the tag is unlikely to affect binding of the
RBD to the ATPase domain face. Control experiments rule out
any deleterious effects of the GST tag and the tag in RUVBL1
(Supplementary Fig. 1).
Together, our interaction mapping reveals a very different
assembly of the PIH domain and TPR domain-containing
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components of human R2TP than in the yeast system24. Instead
of Pih1p acting as the central scaffold that connects the HSP90-
recruitment factor Tah1p to the AAA+ ring, RPAP3 takes at least
part of this role, interacting with HSP90, RUVBL1–RUVBL2 and
PIH1D1, and providing additional domains, which may mediate
recruitment of other factors to the R2TP core27. Most
signiﬁcantly, the primary interaction between the TP component
and the RUVBL1–RUVBL2 heterohexamer in human R2TP,
is mediated by a RUVBL2-binding domain located at the
C-terminus of RPAP3, corresponding to the previously annotated
protein domain (pfam13877).
RPAP3–PIH1D1 but not RBD disrupts dodecameric
RUVBL1–RUVBL2. The cryo-EM images of RUVBL1–
RUVBL2 alone, obtained using the same experimental
conditions as those used later for the full R2TP, showed that
they exist as a back-to-back dodecameric complex with the DII
domains mediating the interaction between two hexamers, and
the ATPase rings facing outward (Fig. 2a), as previously
described28. In all cases, we used Adenosine 5′-diphosphate
(ADP) in the buffer, which stabilizes RUVBL1–RUVBL2-con-
taining complexes29,30. When RUVBL1–RUVBL2 was incu-
bated with a fragment of RPAP3 comprising residues 430–665,
up to 3 RBDs decorated the ATPase face of the RUVBL ring,
one per each RUVBL2 molecule in the complex (Fig. 2b). In
our conditions, one ring in the dodecamer was saturated
whereas the other contained a variable number of RBDs,
indicating we had not reached saturation. The location of the
RBD at the ATPase face was consistent with its binding to
RUVBL2-ΔDII in pull-down experiments (Fig. 1d) and with
cross-links detected between the RBD and residues K453 of
RUVBL1 and K417 in RUVBL2, both exposed at the ATPase
face of the RUVBL ring (Supplementary Fig. 2). These
experiments show that the interaction of RPAP3 residues
430–665, which include the RBD, with RUVBL1–RUVBL2 was
insufﬁcient to disrupt the dodecamer.
R2TP could be reconstituted by mixing RUVBL1–RUVBL2
and RPAP3–PIH1D1 (Fig. 3a). For cryo-EM studies, R2TP was
assembled from RUVBL1–RUVBL2 and RPAP3–PIH1D1 sub-
complexes, each co-expressed and puriﬁed by afﬁnity and gel-
ﬁltration chromatography (Fig. 3b). Images of the fully assembled
human R2TP complex revealed a single hexameric ring of
RUVBL1–RUVBL2 in which its ATPase face was decorated with
the RBD domain of RPAP3 (Fig. 3c, Supplemental Fig. 3). The
remaining regions of RPAP3 appeared as blurred density at the
opposite side of the RUVBL1–RUVBL2 ring, tilted with respect to
the ring, indicative of substantial structural ﬂexibility in their
connection to the core of the complex.
Flexible regions at the opposite end of the RUVBL ring are
attributed to the N-terminal TPR-containing region of RPAP3. In
support of this, this density is absent from the cryo-EM images
when R2TP was reconstituted with a truncated version of RPAP3
(residues 395–665) bound to PIH1D1, but from which the TPR
domains and N-terminus of RPAP3 have been removed (RPAP3-
ΔNT) (Fig. 3d). These images suggested that PIH1D1 located
close to the RUVBL ring, as in yeast24,25. Therefore,
RPAP3–PIH1D1 and RPAP3–ΔNT–PIH1D1 are sufﬁcient to
disrupt the RUVBL1–RUVBL2 dodecamers. Since RPAP3
residues 430–665 bind the RUVBL ring without affecting the
dodecameric assembly of RUVBL1–RUVBL2, our data suggest
that the RPAP3 region that binds PIH1D1 together with PIH1D1
itself are responsible for these effects, likely because it locates
within the DII-domain face of the RUVBL ring, as in yeast24. This
is the side of the RUVBL ring where most protein interactions
have been described in other complexes that contain a
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RUVBL1–RUVBL2 hexamer, such as INO8031. These experi-
ments do not discard that RPAP3 alone could be sufﬁcient to
disrupt the RUVBL1–RUVBL2 dodecamer.
R2TP can engage up to 3 RPAP3 molecules. R2TP images were
classiﬁed according to the number of RBDs per ring, by masking
out the rest of the molecule and without assuming symmetry
(Supplementary Fig. 3). This classiﬁcation revealed that most of
the RUVBL rings contained 3 RBDs (>67%), suggesting that
R2TP can incorporate up to 3 RPAP3 molecules, one for each
RUVBL2 in the complex. This was also the subgroup where the
RBDs displayed better quality in the cryo-EM images. It is
noteworthy that several orientations of R2TP complexes con-
taining 3 RBDs may seem to contain only 2 apparent RBDs in the
two-dimensional (2D) averages (Fig. 3c), but this is because 2
RBDs coincide in the same direction of the projection for many of
the most abundant rotations of R2TP along its longitudinal axis
in our data set, thus masking each other (Supplementary Fig. 3).
Images of the most abundant, RBD-saturated complex were
then processed applying 3-fold symmetry (Fig. 3e). The structure
revealed a RUVBL1–RUVBL2 hexamer decorated by 3 RBDs.
However ﬂexible regions located at the opposite end of the
RUVBL ring did not follow the 3-fold rotational symmetry. These
regions included the TPR end of RPAP3, which was mapped
using RPAP3-ΔNT (Fig. 3d), and also a density in the DII-face of
the RUVBL ring that should contain PIH1D1. The rigid and
ﬂexible segments of R2TP were processed separately with
dedicated image processing strategies (see later).
Cryo-EM structure of the RUVBL1–RUVBL2–RBD complex.
The structure of RUVBL1–RUVBL2–RBD was ﬁrst resolved
using 3-fold symmetry, revealing a helical domain bound to each
RUVBL2 in the hexameric ring (deposited as R2TP-C3 symmetry
in EMDB) (Fig. 4a). When the processing was performed without
symmetry, small differences in the quality of each RBD in the ring
were observed. Thus, to attain maximum resolution of the
RUVBL1–RUVBL2–RBD interaction, particles were rotated by
120 and 240° so that each of the 3 RBDs in every particle was
placed in the same position, allowing the classiﬁcation of all the
available RBD data (Fig. 4b, c). Similar methodology was applied
previously by others to resolve the cryo-EM structure of the
apoptosome32 (see details in Methods). Three-dimensional (3D)
classiﬁcation generated subgroups corresponding to small
differences in some of the α-helices of the RBD, and the one
that reached the best resolution was reﬁned locally to an
estimated average resolution of 3.6 Å (Supplementary Fig. 3).
Analysis of the local resolution revealed that most of the
map showed resolutions between 3.0 and 3.5 Å, with some
external parts ranging between 3.5 and 5 Å (deposited as
R2TP–1RBD in EMDB) (Fig. 4b). The RBD structure revealed a
α-helical domain sitting on top of each RUVBL2 subunit,
projecting out from the ATPase domain face of the
RUVBL1–RUVBL2 ring (Fig. 4c).
Previously described interactions with RUVBL1–RUVBL2 such
as in SWR133, INO8011, or yeast R2TP24,25 are mediated by the
face of the ring presenting the DII ‘insertion’ domain. Interaction
with the opposite ATPase domain face of the RUVBL1–RUVBL2,
as seen here with RPAP3-RBD, has not previously been found,
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although contacts between this face of the RUVBL ring have been
observed in crystals of Rvb1/Rvb2 dodecameric complexes34.
RPAP3–RBD recognizes speciﬁc features in RUVBL2. Side
chains and other high-resolution details are clearly visible in the
RUVBL1–RUVBL2 component of the map (Supplementary
Fig. 4), such as the ADP density and the surrounding side chains,
allowing an accurate atomic modeling of these two proteins in the
complex. As no experimental crystallographic or Nuclear
magnetic resonance (NMR) structure has been reported for the
RPAP3-RBD, a structural model was generated using the
I-TASSER server35, which predicted that residues 541–665
comprise 8 highly conserved α-helices preceded by a long and
poorly structured region (Supplementary Fig. 4). Attempts to
crystallize the RBD resulted in a crystal structure at 1.8 Å reso-
lution of a proteolytic fragment comprising residues 578–624
(deposited as 6FM8 in PDB). This fragment accounted for a third
of the RBD domain approximately, including most of helix 3, and
the complete helices 4 and 5 (Fig. 5a). The crystal structure
supported assignment of the correct register of amino acids, and
it helped to model the connection between helices 5 and 6. The
conformation of such a short segment will be strongly inﬂuenced
by crystal packing, and thus the overall conformation of the RBD
observed in cryo-EM was considered for the model. The dis-
position of secondary structure elements in the prediction clearly
matched the density for the RBD we observed in the
cryo-EM, and the model was then ﬂexibly ﬁtted within the map
(see Methods for details) (Supplementary Movie 1). The
ﬁtted structure of the RBD and the crystal structure of the
RUVBL1–RUVBL2 hetero-hexamer (PDB 2XSZ)29 were reﬁned
in Phenix.reﬁne and adjustments made in COOT36. The atomic
model obtained (Fig. 5b) showed good cross-correlation with the
cryo-EM map (Supplementary Fig. 4). Density for side chains
were also visible in most of the helices of the RBD (Supplemen-
tary Fig. 5), and this, together with the crystal structure of the
RBD fragment, were used to tune and validate the ﬁtting of the
atomic model into the cryo-EM map. Nonetheless, some side
chains in the interaction surface between RUVBL1–RUVBL2
and RBD are not well deﬁned, and thus detailed protein–protein
interactions are mostly discussed at the level of secondary
structural elements, except where side chain density was clear.
We subjected the assembled complex to analysis by cross-
linking mass spectrometry (XL-MS) (Supplementary Fig. 2). XL-
MS identiﬁed cross-links between residue K453, a lysine in
RUVBL1 C-terminal helix, and K622 in RPAP3, and between
K417 in RUVBL2 and K495 in RPAP3—both cross-links are
compatible with the structure (Fig. 5c). Although the bound
RPAP3-RBD is proximal to some regions in RUVBL1 and an
RPAP3–RUVBL1 cross-link was observed, as expected from the
pull-down data, the bulk of the RPAP3 interaction with the
AAA+ ring occurs with RUVBL2, and is mediated by selective
interaction with conserved features that are absent in RUVBL1
(Fig. 5b). As a control during the adjustment of the RBD model
into the cryo-EM map, we found that any ﬁtting in the reverse
N- and C-terminal orientation did not agree with the cryo-EM
density but, in addition, was incompatible with the XL-MS data.
RPAP3–RBD is comprised of 8 helical segments (H1 to H8),
and they make contacts with RUVBL2 through H1, H6, and the
loop connecting H5 and H6 (Fig. 5b). Although no secondary
structure is predicted for RPAP3 immediately N-terminal of H1,
the electron density for this segment was good enough to model a
loop between Leu541 and Asn548 based on the presence of three
prolines (Pro543, Pro544, Pro546) (Fig. 5b). This loop leads
toward the outer edge of the RUVBL1–RUVBL2 ring (see later).
H1 contacts the C-terminal region of RUVBL1 (Fig. 5b), whereas
H6 sits between 2 helixes of RUVBL2 that are positioned in a V-
shape fashion (Figs. 5b, 6a). The V-shaped fold of RUVBL2 that
accommodates H6 of the RPAP3–RBD is rich in positively
charged amino acids such as Arg392, which is moved away from
its location in the crystal structure of RUVBL1–RUVBL2 alone
(PDB 2XSZ)29 (Fig. 6a), suggesting that it may be repositioned to
avoid clashing and/or to make contacts with the RBD. Density for
the side chain of Arg623 of the RBD is also well deﬁned, pointing
toward residues in RUVBL2, with which it may establish contacts
(Fig. 6a).
The RPAP3–RBD is strongly conserved in chordates, and the
amino acid sequences of H1 and H6 are identical in humans, rats,
mice, chicken, and Xenopus (Fig. 6b, Supplementary Fig. 4, 100%
identical regions labeled in red color), highlighting its functional
importance, most likely for the interaction with RUVBL2. The
regions of RUVBL2 that interact with RPAP3-RBD are also very
well conserved, but these are also conserved in yeast suggesting
that RPAP3, and not RUVBL2, evolved to exploit the character-
istics of this region in RUVBL2.
RPAP3 loops around the RUVBL1–RUVBL2 hexamer.
Cryo-EM images of R2TP suggested that the RPAP3 molecules
span both faces of the RUVBL1–RUVBL2 ring (Fig. 3c). This
would be facilitated by the long unstructured region (residues
420–540) that connects the tandem TPR domains and PIHID1-
binding region of RPAP3 to the C-terminal RBD (Fig. 1a). In an
extended conformation, this segment could comfortably stretch
over several nanometers, allowing the RBD to bind on one face of
RUVBL1–RUVBL2, while the rest of RPAP3 is located on the
a b
 V541
 G665
RUVBL2
H1
H6
H6
R392
D435
R623
R392 (in
2XSZ)
Fig. 6 Structural details of RUVBL1–RUVBL2–RBD. a R392 residue in RUVBL2 of the RUVBL1–RUVBL2–RBD complex (model in blue color within the
density) shows a different conformation to its position in the crystal structure of RUVBL1–RUVBL2 (structure in gray color) (PDB 2XSZ)29. R623 in RBD is
also visible and pointing toward RUVBL2. b Helix 1 and 6 are 100% identical in those species analyzed (red color). Other regions shown in magenta color
also revealed high conservation
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opposite face of the ring. The visible N-terminal loop on the RBD
(Leu541–Asn548) comes in from the edge of the ATPase domain
face (Fig. 5b), suggesting that the preceding polypeptide chain
runs across the rim of the RUVBL1–RUVBL2 ring. Consistent
with such a trajectory, we identiﬁed a cross-link between RPAP3-
Lys495, which lies within the unstructured region, and RUVBL2-
Lys417, which projects from the rim of the RUVBL1–RUVBL2
ring (Fig. 5c).
RPAP3 provides a ﬂexible tether for HSP90. Human R2TP was
fully competent to bind HSP90 and this interaction is mediated
by the TPR domains in the N-terminal half of RPAP3
(Supplementary Fig. 6). Unlike the RBD, which is rigidly bound,
this region is disordered relative to the RUVBL1–RUVBL2
(Fig. 3). Two image-processing strategies were used to deﬁne the
structure of the ﬂexible regions in R2TP comprising the TPR
domains of RPAP3 and PIH1D1.
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Fig. 7 Structural analysis of the ﬂexible region in R2TP. a Side and bottom view of the output 3D classiﬁcation for a subset of particles with a more
homogenous conformation for the ﬂexible regions. Scale bar, 2.5 nm. b Low-resolution structure of PIH1D1 region in R2TP complexes. Density for PIH1D1,
highlighted in orange color. Scale bar, 2.5 nm. c One view of the structure of yeast R2TP (EMD 3678)24. Rvb1–Rvb2 is shown in white transparency whilst
the density for the yeast Tah1p–Pih1p complex is shown in orange color
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Extensive classiﬁcation was used to select a subset of particles
displaying a more homogenous conformation in the ﬂexible
regions (deposited as R2TP-subgroup1 in EMDB) (Fig. 7a). In
this structure, several compact densities were resolved on the DII
domain face of the RUVBL ring. Densities at the further end of
the complex, opposite to the RUVBL ring, had been assigned as
comprising the N-terminal region of RPAP3 and the TPR
domains (Fig. 3d), and dimensions were sufﬁcient to accom-
modate the TPR domains of 3 RPAP3 subunits. This interpreta-
tion was further supported by images of R2TP reconstituted using
N-terminally GST-labeled RPAP3, where the additional density
for the GST fusion mapped to the face of the RUVBL ring
opposite to that bound by the RBD (Supplementary Fig. 6). On
the other hand, density for PIH1D1 located within the DII region
beneath the RUVBL ring.
To analyze the region around PIH1D1, images corresponding
to R2TP complexes containing 3 RBDs were classiﬁed and aligned
masking out ﬂexible regions except for the vicinities of the
RUVBL1–RUVBL2 ring, and image processing was performed
without applying any symmetry. This approach resolved a clear
region of density within the cage formed by the DII domains in
the RUVBL ring (deposited as R2TP-subgroup2 in EMDB)
(Fig. 7b), in a similar position to that occupied by Pih1p and
Tah1p in yeast R2TP24 (Fig. 7c). As in the yeast system, the
inherent ﬂexibility of this region did not permit a sufﬁciently high
resolution to clearly deﬁne secondary structure elements.
Discussion
HSP90 is required for the stabilization, activation, and assembly
of a diverse range of proteins and complexes involved in cellular
processes as fundamental and as varied as transcription, cell cycle
progression, centrosome duplication, telomere maintenance,
siRNA-mediated gene silencing, apoptosis, mitotic signal trans-
duction, innate immunity, and targeted protein degradation37.
HSP90s ability to chaperone this very broad protein clientele is
provided by co-chaperones38, which act as adaptors, facilitating
recruitment of client proteins to HSP90.
R2TP/PFDL is the most complex HSP90 co-chaperone yet
described, and is known to facilitate HSP90s participation in the
assembly of RNA polymerases, PIKK complexes, and
snoRNPs39,40, although this list is likely to be far from complete.
It recruits HSP90 via its TPR domain component Tah1p or
RPAP3, and at least some of its clientele through a CK2
phosphorylation-dependent interaction with the PIH domain of
Pih1p/PIH1D12,3. The best characterized of these interactions
involves Tel2p/TELO2, itself a component of an additional
‘adaptor’ layer, the TTT complex (Tel2p/TEL2, Tti1p/TTI1, and
Tti2p/TTI2), which ultimately bridges R2TP, and thereby HSP90,
to PIKK proteins7,41,42. Comparable PIH-binding motifs can be
identiﬁed in a range of other proteins in yeast and metazoa,
suggesting that there are many R2TP-mediated HSP90 depen-
dencies yet to be described, some of which will likely also involve
multiple adaptor systems.
The structure of the human R2TP core components revealed
here is well suited to deal with a high degree of diversity in the
client proteins it brings to HSP90 (Fig. 8). In both yeast and
human R2TP, a PIH domain client-recruitment component maps
to the same face of the RUVBL ring as the TPR domain(s)
necessary for HSP90 recruitment, facilitating direct interaction of
the chaperone and the client (or at least client adaptor).
In the yeast system, the single TPR domain of Tah1p is part of
a well-ordered cluster of domains along with the CS and PIH
domains of Pih1p, that lies in the cup formed by the DII domains
of the RUVBL ring24,25. Conformational adaptability in the yeast
system is thus limited to the inherent ﬂexibility of the ~30
residues linking the last globular domain of the bound HSP90 to
the TPR-binding MEEVD motif at its extreme C-terminus.
The much more elaborate structure of RPAP3 in human R2TP
allows for a far greater level of adaptability, while retaining the
topological proximity of TPR and PIH domains required to
bring HSP90 and client together. RPAP3 is divided into two
regions that are located at the two opposite faces of the
RUVBL1–RUVBL2 ring. As revealed in our cryo-EM structures,
the interaction of the RBD of RPAP3 with the ATPase face of the
RUVBL1–RUVBL2 ring provides a tight anchor for the
C-terminus of the protein, while allowing considerable ﬂexibility
for the CS-binding segment, TPR domains and N-terminus of the
protein on the other face, coupled to the RBD by the long ﬂexible
central segment that spans the rim of the ring.
As the necessary and sufﬁcient interaction of the C-terminal α-
helical bundle RBD of RPAP3 occurs with a surface of RUVBL2
presented on the ‘uncluttered’ ATPase face, the heterohexameric
RUVBL ring is capable of binding up to 3 RPAP3 molecules, and
the presence of 3 symmetrically equivalent RBDs is evident in
cryo-EM images of saturated complexes. Nonetheless, the num-
ber of RPAP3 molecules per RUVBL ring in vivo, and/or in the
context of a larger assembly, cannot be determined by our work.
Cryo-EM shows that PIH1D1, with which RPAP3 also interacts,
binds asymmetrically to the DII domain-face of the ring in a
similar location as in the yeast R2TP complex24,25. The
RPAP3–PIH1D1 sub-complex behaved as an elongated hetero-
dimer in sedimentation velocity experiment, with an estimated
average molecular mass of 103,900 ± 320 Da determined by
sedimentation equilibrium assays (Supplementary Fig. 6), which
corresponds to a 1 RPAP3:1 PIH1D1 heterodimer (104,212 Da).
We have been unable to deﬁne PIH1D1 within R2TP at high
resolution, due to the ﬂexibility in this region. However, based on
the dimensions of this region in the maps, we speculate that it
could be conceivable that the RUVBL ring may only
accommodate 1 PIH1D1 molecule, as in yeast24,25. In this
hypothetical scenario, while three RPAP3 molecules may simul-
taneously bind to the three RUVBL2 subunits in the AAA-ring,
only one at a time could be fully engaged through the additional
interaction with the single copy of PIH1D1. This could provide a
mechanism whereby multiple copies of HSP90, bound to the TPR
domains, could be brought to bear, or additional client
components potentially recruited via the poorly understood
N-terminal region of RPAP3, could be introduced—further work
will be required to test these possibilities.
The R2TP core complex analyzed here was reconstituted
in vitro, without subunits of the associated PFDL module or other
interacting proteins whose presence would add still further
complexity. These additional components may facilitate
recruitment of speciﬁc clients, such as RNA Pol II or PIKKs, but
may also have important functional inﬂuence on the conforma-
tional state of the R2TP core components. It is also likely that
there will be steric competition or collaboration between
some of these additional components. For instance, the ZNHIT2
protein was recently found to bind RUVBL2 and it has
been proposed to bridge R2TP and U5 snRNP5. The structure of
the RUVBL1–RUVBL2–RBD complex we describe here raises
the possibility that RPAP3 and ZNHIT2 could either compete
or collaborate for binding to RUVBL2. Since each
RUVBL1–RUVBL2 ring contains 3 RUVBL2 molecules, com-
plexes containing RPAP3 and ZNHIT2 proteins could be also
conceptually possible.
Along with the structure of the yeast R2TP complex24,25, the
cryo-EM structure of the human R2TP core presented here
provides a clear understanding of the architecture and evolution
of this complex HSP90 co-chaperone. These studies suggest a
mechanism for how R2TP brings HSP90 and clients (or client
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adaptors) into proximity, and at least for yeast suggest some
involvement of the ATPase activity of the RUVBL proteins in
modulating this, although the signiﬁcance of this for R2TP
function in vivo is far from clear. The ultimate question of how
HSP90 functions with R2TP/PFLD to facilitate the assembly of
large multiprotein complexes such as Pol II remains to be
determined.
Methods
Cloning. N-terminal His-tagged RuvBL1 and untagged RuvBL2 were cloned as
indicated in Lopez-Perrote et al.28. For pull-down experiments, a 3xMyc tag was
incorporated to the N-terminus of RUVBL1. The RPAP3 full length (FL) was
purchased from GenScript. The RPAP31-430, RPAP31-400, RPA31-420, RPAP3395-665,
RPAP3430-665, RPAP3523-665, RPAP3430-541, RPAP3541-665, and RPAP3395-665
(RPAP3-ΔNT) gene truncations were cloned using NdeI sites and ligation-free
cloning using infusion cloning (Clonetech lab Inc.) into a modiﬁed pGex6p
modiﬁed plasmid named p3E (University of Sussex, UK), which resulted in
N-terminal GST-tagged RPAP3 genes (Supplementary Table 1).
The human PIH1D1 full-length gene and PIH1D1180-290 truncated genes were
cloned into a pET28b using NdeI site, which resulted in 6XHis-hPIH1D1. PIH1D1
constructs were co-expressed with RPAP3 since PIH1D1 was insoluble when
expressed alone. RuvBL1 full-length gene was cloned into NheI and BamHI sites of
a modiﬁed pRSETA plasmid (containing 3×Myc tags) and RuvBL2 gene was cloned
into pET28b using NdeI and BamHI sites. Human Hsp90 full-length beta gene was
cloned into modiﬁed pET28b plasmid (contacting 6His-2Xstrep-tags) using NdeI,
which resulted in 6His-2Xstrep-PreSc-Hsp90FL beta gene.
Protein expression and puriﬁcation. The human RUVBL1–RUVBL2 protein
complex and RUVBL2 used in the pull-down experiments, and human HSP90 beta
were transformed into Rosetta (DE3) pLysS cells (F−ompT hsdSB(rB− mB−) gal dcm
(DE3) pLysSRARE (CamR), Merck Millipore Ltd.). The cells were grown in the
presence of ampicillin and kanamycin antibiotics at 37 °C until the cells reached
their log-phase. Then the cells were induced by the addition of 1 mM IPTG. The
cells were further grown at 25 °C overnight for protein expression. The cell mass
was pelleted by spinning the cell culture at 6238×g for 10 min. The cells were lysed
using a sonicator in 20 mM HEPES pH 7.5, 140 mM NaCl (HEPES buffer) and 1
tablet of EDTA-free protease inhibitor (Sigma-Aldrich Ltd.). The cell lysate was
centrifuged at 20,000×g for an hour at 4 °C. The clear supernatant was loaded on to
the equilibrated Talon beads in 20 mM HEPES pH 7.5, 140 mM NaCl for His-tag
afﬁnity-chromatography. The beads were washed with HEPES buffer to remove the
contaminant proteins. The proteins of interest were eluted with 500 mM imidazole
in HEPES buffer. The eluted proteins were analyzed by 4–12% SDS-PAGE and
concentrated to 6 mgml−1 using viva-spin (MWCO 10K, Sartorius). The proteins
were further puriﬁed by size-exclusion chromatography (SEC) using S200 10/300
column (GE Healthcare Ltd.). The GST-tagged RPAP3FL and RPAP3 shorter gene
constructs alone and in complex with PIH1D1 full length and PIH1D1180-290 were
expressed in Rosetta (DE3) pLysS cells. The cells were lysed similar to RUVBL1/2
and HSP90 beta. The proteins were puriﬁed using GST-tag afﬁnity chromato-
graphy by adding the clear cell lysate to the GST-beads. The GST-bound proteins
were washed with HEPES buffer and they were eluted with 50 mM glutathione. The
proteins were incubated with PreScission protease (3C protease) to cleave the GST-
tag at 4 °C overnight and the proteins free of GST-tag were concentrated to 20 mg
ml−1 using viva-spin with MWCO of 10k. The proteins were further puriﬁed by gel
ﬁltration chromatography using S200 26/60 column in degassed 20 mM HEPES pH
7.5, 500 mM NaCl. For those pull-down experiments using untagged RUVBL1,
6xHis-tagged RUVBL1 was puriﬁed and the tag cleaved using PreScission protease.
RUVBL1–RUVBL2 complexes used for cryo-EM studies were produced and
puriﬁed as before28. N-terminal His10-tagged human RuvBL1 and untagged human
RuvBL2 were co-transformed into Escherichia coli BL21 (DE3) cells grown in LB
medium. The lysate was applied to a HisTrap HP column (GE Healthcare)
equilibrated in 50 mM Tris-HCl pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, and 20
mM imidazole. Elution was performed using a 20–500 mM imidazole gradient,
followed by a preparative SEC using a Sephacryl S300 column (GE Healthcare)
equilibrated in 50 mM Tris, 300 mM NaCl and 1 mM DTT. The uncropped SDS-
PAGE gels of the SEC of the RUVBL1–RUVBL2 and RPAP3–PIH1D1 used for
cryo-EM are shown in Supplementary Fig. 7. The puriﬁcation was monitored by
SDS–PAGE. RUVBL1 used for the pull-down experiments contained an N-
terminal 3xMyc tag, to help distinguish RUVBL1 and RUVBL2 in SDS-PAGE.
Pull-down assay for interaction mapping. Twenty micromolar GST-RPAP3 (full
length and different lengths of RPAP3) and RPAP3–PIH1D1 and
RPAP3–PIH1D1180–290 complexes were mixed with 30 μl GST beads, which were
equilibrated in 50 mM HEPES pH 7.5, 140 mM NaCl. Sixty micromolar of the
RUVBL2 alone and RUVBL1–RUVBL2 complex were added to the above mixture
for the interaction mapping study. In these experiments, a 3xMyc tag was incor-
porated to the N-terminus of RUVBL1 to help in distinguishing RUVBL1 and
RUVBL2 in SDS-PAGE. The above reaction mixture was incubated for 45 min at 4
°C rotating at 20 rpmmin−1. The beads were washed three times with 500 μl of
HEPES buffer and the bound fraction was eluted with 50 mM glutathione.
Human R2TP complex assembly was monitored by pull-down. For this, the
puriﬁed RPAP3–PIH1D1 and RUVBL1–RUVBL2 proteins were used for the R2TP
complex assembly. The 20 μM GST–RPAP3–PIH1D1 complex and 60 μM
RUVBL1–RUVBL2 proteins were used in the experiments; 30 μl GST-beads (GE
Healthcare) equilibrated in 50 mM HEPES pH 7.5, 140 mM NaCl (HEPES buffer)
were added to the above protein complexes. Then the protein mixture was
incubated for 45 min rotating at 20 rpm at 4 °C. The beads were washed three times
with HEPES buffer to remove the non-speciﬁc proteins bound on to the GST-
beads. The bound fraction was eluted with 50 mM glutathione in 20 mM HEPES,
pH 7.5, 140 mM NaCl. For the co-expression experiments shown in Fig. 1, we co-
expressed Gst-RPAP3FL, Gst-RPAP3FL-RuvBL2FL, Gst-RPAP3541–665-RuvBL2FL
and Gst-RPAP3541–665-RuvBL2 ΔDII. The interactions were analyzed using GST-
afﬁnity chromatography and the bound fractions were eluted with 50 mM
glutathione in the 20 mM HEPES pH 7.85, 140 mM NaCl, and the quality of the
protein complex was visualized using SDS-PAGE.
Cryo-EM of human R2TP. To image R2TP at high resolution, 0.45 μM
RUVBL1–RUVBL2 (estimated as dodecamers) was incubated with 9 μM of
RPAP3–PIH1D1 complex for 20 min in ice and the mix dialyzed for 5 h against 25
mM HEPES pH 7.8, 130 mM NaCl, 10 mM 2-Mercaptoethanol. After dialysis, the
sample was recovered and incubated with ADP (pH 7.0) for 1 h at a ﬁnal con-
centration of 0.5 mM. Subsequently, aliquots of 2.5 μl were applied to Quantifoil
R1.2/1.3 carbon grids after glow-discharge, and then ﬂash frozen in liquid ethane.
An initial test data set was obtained in Grenoble Instruct Center, France, using a
FEI Polara microscope operated at 300 kV. High-resolution structures were
obtained from data collected in a Titan Krios (eBIC, Diamon, Oxford, UK),
automatically, with three images per hole, using a GATAN K2-Summit detector in
counting mode and a slit width of 20 eV on a GIF-Quantum energy ﬁlter (Sup-
plementary Tables 2, 3).
High-resolution image processing of RUVBL1–RUVBL2–RBD. As general
methodology, MotionCorr243 was used for whole-frame motion correction,
GCTF44 for estimation of the contrast transfer function parameters, and RELION-
2.045 for all subsequent steps. Local motion was corrected in MotionCorr2 dividing
the frame in 36 patches (6 × 6 patches), with dose weighting. A manually picked
subset of micrographs was used to obtain 2D references for template-based particle
picking. The selected particles were then submitted to several rounds of 2D and 3D
classiﬁcations, to discard low-quality particles and some remaining
RUVBL1–RUVBL2 dodecamers. Low-pass ﬁltered versions of previous structures
were used as starting point of classiﬁcations and reﬁnements, to reduce bias.
A speciﬁc classiﬁcation protocol was designed to analyze the stoichiometry of
RBDs bound to the RUVBL ring. For this, Class3D in RELION was used but using
a mask covering the edge of the RUVBL ring and the regions outside the ring.
Particles were split in up to eight groups using this focused classiﬁcation strategy.
The majority of particles were grouped into one class, containing 3 RBDs and
corresponding to 67.3% of the particles. The remaining classes corresponded to
particles containing 2 RBDs (16.4%) or 1 RBD (16.3%). Images of R2TP containing
3 RBDs were then processed applying 3-fold rotational symmetry and using
standard procedures in RELION45.
For the reﬁnement of the RUVBL1–RUVBL2–RBD complex at high resolution,
96,406 particles showing the best parameters after 2D classiﬁcation in RELION
were selected and subjected to a round of automatic 3D reﬁnement in RELION to
generate a consensus 3D model. When reﬁnement was performed without applying
rotational symmetry, similar results were obtained, but some differences in the
quality of the different RBDs bound to one RUVBL ring, suggested that the
complex had a rigid conformation at the RUVBL ring, and relatively ﬂexible RBDs
(or variable quality). To improve the quality of the structure deﬁning the
interaction between the RBD and the RUVBL ring, we applied the method
previously developed to solve a similar situation for the structure of the
apoptosome32. For this, each particle was rotated 120 and 240° so that all RBDs
were then placed in the same position. Subsequently, particles were classiﬁed using
the Class3D utility in RELION and using a mask representing 1 RBD and the ring
of RUVBL1–RUVBL2. The most populated class was automatically reﬁned using
the Ref3D utility using the same mask used for Class3D, local search of angles and
without applying symmetry. Further details on the strategy applied here can be
found in the Methods section of Zhou et al.32. When applied to our data, resolution
was improved from 3.8 Å when applying 3-fold rotational symmetry to 3.57 Å,
estimated using gold standard Fourier Shell Correlation (FSC) between two
independent maps using cut-off of FSC= 0.143. B factor sharpening was
performed using automatic procedures in Relion2. Local resolution was estimated
using ResMap46. Structures were visualized using UCSF Chimera47.
Cryo-EM and processing of RUVBL1–RUVBL2–RBD and R2TP-ΔNT. The
reconstitution of complexes between RUVBL1–RUVBL2 and RPAP3430–665, and
the reconstitution of R2TP using the RPAP3–ΔNT–PIH1D1 sub-complex instead
of RPAP3–PIH1D1 were performed with the same protocol used for the R2TP used
in cryo-EM experiments. For consistency, all these observations were performed
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with the same buffer conditions used for the assembly of R2TP, and in the presence
of ADP. Vitriﬁcations, the general image processing, 2D classiﬁcations, and the
generation of 2D averages and 3D volumes were performed following similar
strategies to those described for the R2TP images, but the cryo-EM micrographs
were collected in a 200-kV FEI Talos Arctica operated with a FEI Falcon II detector
and located at the Centro Nacional de Biotecnologia (CNB) in Madrid.
Image processing of ﬂexible regions. For reﬁnement of the ﬂexible regions of the
R2TP complex, the same set of 96,406 particles used to resolve the structure of
RUVBL1–RUVBL2–RBD was classiﬁed searching for a subset of particles of R2TP
with a more homogenous conformation for the ﬂexible regions after extensive 3D
classiﬁcation steps using Relion. This subset, containing a selection of 27,385
particles, was then reﬁned, converging to a structure with an estimated average
resolution of 8.72 Å using gold standard Fourier Shell and FSC= 0.143.
To analyze the structural details for the interaction between PIH1D1 and
RUVBL1–RUVBL2, the images of R2TP complexes containing 3 RBDs were
reﬁned without symmetry and using a mask that removed the inﬂuence of the
ﬂexible regions except the vicinities of the DII domains in RUVBL1–RUVBL2.
One subset of 182,351 particles corresponding to complexes containing 3 RBDs
and that displayed a deﬁned density in DII-domain face of the RUVBL1–RUVBL2
reached an estimated resolution of 6.58 Å using gold standard Fourier Shell and
FSC= 0.143.
Modeling and reﬁnement of RUVBL1–RUVBL2–RBD. De novo modeling of the
C-terminal domain of RPAP3 was performed using a strategy based on homology
modeling and molecular dynamics simulation. First, analysis of the sequence in the
secondary structure prediction server PSIPRED revealed 8 α-helices consecutively,
starting from Ala547 to C-terminus Gly665. A long and disordered region of
RPAP3 N-terminal to this helical domain contributed to a clear identiﬁcation of
the domain. The sequence of RPAP3-RBD domain (residues 541–665) was sub-
mitted to I-TASSER homology modeling server35, which provided up to ﬁve dif-
ferent atomic models for the query sequence. The best solution according to the I-
TASSER scoring was ﬁtted within the target cryo-EM map.
The target cryo-EM map density contained 8 α-helices, the same as the
predicted atomic model in I-TASSER. The prediction was ﬁrst ﬁtted as a rigid body
in the map, followed by a ﬂexible ﬁtting using molecular dynamics (MD)
simulations in AMBER48 (Supplementary Movie 1). Flexible ﬁtting was performed
in two orientations: one from the initial ﬁtted conformation and the second forcing
the reverse orientation as control. The reverse orientation was discarded since no
reasonable ﬁtting of the model into the cryo-EM map was possible after the
simulation.
A model for RUVBL1–RUVBL2–RBD was built initially by the ﬁtting as a rigid
body of the crystal structure of the human RUVBL1–RUVBL2 truncated hexamer
(PDB 2XSZ)29 into the cryo-EM map with the addition of the model generated for
the RBD using AMBER. The full structure of the RUVBL1–RUVBL2–RBD was
reﬁned using Phenix49 and Coot36.
The information of the crystal structure of the RPAP3 fragment comprising
residues 578–624 helped to model the connectivity between helix 5 and helix 6 of
the RBD, which faces RUVBL2. Density for side chains was also visible in most of
the helices of the RBD (Supplementary Fig. 5), and this information was used
during modeling. Detailed protein–protein interactions are mostly discussed at the
level of secondary structural elements, except where side chain density was clear.
R2TP reconstitution and puriﬁcation using GraFix. For the experiments using
GraFix50, the different complexes were analyzed using a linear 10–40% sucrose
gradient together with a 0–0.15% of glutaraldehyde gradient. Fifty microliters of the
mixture were used for each gradient and run at 125812 g using a SW60Ti rotor, 16
hours and 4 °C. Fractions of 100 μl were collected from top to bottom of the
gradient, the ﬁxation reaction was stopped by adding glycine pH 7.0 at ﬁnal
concentration of 100 mM. Blue-Native system (Invitrogen) was used to analyze the
fractions.
Cross-linking coupled to mass spectrometry. R2TP was reconstituted as
for the cryo-EM experiments and cross-linked with isotopically coded N-hydro-
xysuccinimide (NHS) esters disuccidinimidyl suberate (DSS H12/D12) and bis-
sulfosuccidinimidyl suberate (BS3 H12/D12) (Creative Molecules, Canada) at a ﬁnal
excess concentrations of 100 and 250×. The reactions were incubated for 45 min at
37 °C, and quenched by adding 50 mM NH4HCO3 (ﬁnal concentration) for
another 15 min.
The cross-linked sample was freeze-dried and then resuspended in 50 mM
NH4HCO3 to reach 1 mgml−1 ﬁnal protein concentration. The sample was then
reduced using 10 mM DTT and alkylated with 50 mM iodoacetamide.
Subsequently, proteins were digested with trypsin (Promega, UK) using 1:20
enzyme-to-substrate ratio, at 37 °C, and the incubation was done overnight. A ﬁnal
concentration of 2% (v/v) formic acid was added to acidify the samples, and the
peptides were fractionated by peptide SEC in a Superdex Peptide 3.2/300 column
(GE Healthcare) with 30% (v/v) acetonitrile/0.1% (v/v) TFA as mobile phase and
using a ﬂow rate of 50 μl min−1. Fractions were collected, lyophilized, and
resuspended in 2% (v/v) acetonitrile and 2% (v/v) formic acid.
Fractions were analyzed by nano-scale capillary LC–MS/MS using an Ultimate
U3000 HPLC (ThermoScientiﬁc Dionex, USA) and a ﬂow of approximately 300 nl
min−1. Peptides were separated on a C18 Acclaim PepMap100 3 μm, 75 μm× 250
mm nanoViper (ThermoScientiﬁc Dionex, USA) and eluted with a acetonitrile
gradient. The analytical column outlet was directly interfaced via a nano-ﬂow
electrospray ionization source, with a hybrid dual pressure linear ion trap mass
spectrometer (Orbitrap Velos, ThermoScientiﬁc, USA). A resolution of 30,000 was
used for data-dependent analysis for the full mass spectrometry spectrum, followed
by 10 MS/MS spectra in the linear ion trap. Mass spectrometry spectra were
collected over a 300–2000 m/z range. MS/MS scans were collected using threshold
energy of 35 for collision-induced dissociation.
For data analysis, Xcalibur raw ﬁles were converted into the open mzXML
format through MSConvert (Proteowizard) with a 32-bit precision, and the
converted ﬁles were directly used as input for xQuest searches on a local
installation (http://prottools.ethz.ch/orinner/public/htdocs/xquest/). The following
criteria were used for the selection of cross-linked precursor MS/MS data: a mass
shift of 12.07532 Da among the heavy and the light cross-linkers; precursor charge
ranging from 3+ to 8+; maximum retention time difference 2.5 min. Searches were
performed against an ad hoc database containing the RUVBL1, RUVBL2, PIH1D1,
and RPAP3 sequences plus their reverse as decoy. A number of parameters were set
to perform the xQuest searches: maximum number of missed cleavages (excluding
the cross-linking site) 3; peptide length 4–50 amino acids; ﬁxed modiﬁcations
carbamidomethyl-Cys (mass shift 57.02146 Da); mass shift of the light cross-linker
138.06808 Da; mass shift of mono-links 156.0786 and 155.0964 Da; MS1 tolerance
10 ppm, MS2 tolerance 0.2 Da for common ions and 0.3 for cross-link ions; search
in enumeration mode (exhaustive search). The following criteria were used to ﬁlter
search results: MS1 mass tolerance window −3 to 7 ppm. Finally, each MS/MS
spectra was manually inspected and validated.
Sedimentation velocity assay of TP complex. Four-hundred microliters of 10
μM and 5 μM RPAP3–PIH1D1 prepared in 25 mM Hepes, 130 mM NaCl, 0.1 mM
TCEP, pH 7.8, were loaded into analytical ultracentrifugation cells. The experi-
ments were carried out at 10 °C and 149,103×g in an XL-I analytical ultracentrifuge
(Beckman-Coulter Inc.). This was equipped with UV-VIS absorbance and Raleigh
interference detection systems, and the sedimentation proﬁles were recorded at
280 nm. Least-squares boundary modeling of sedimentation velocity data and the
continuous distribution c(s) Lamm equation model was used to calculate
sedimentation coefﬁcient distributions, as implemented by SEDFIT 14.151. The
program SEDNTERP52 was used to correct experimental s values to standard
conditions (water, 20 °C, and inﬁnite dilution) to obtain the corresponding
standard s values (s20,w).
Sedimentation equilibrium assay. Short column (90 μl) Sedimentation Equili-
brium experiments were carried out at speeds ranging from 4536×g to 6532×g and
at 286 nm, and using the same experimental conditions as those described for the
Sedimentation Velocity experiments. A high-speed centrifugation run using
185,795×g was performed to estimate the corresponding baseline offsets after the
last equilibrium scan. Weight-average buoyant molecular weights of proteins were
determined by ﬁtting a single species model to the experimental data using the
HeteroAnalysis program, and corrected for solvent composition and temperature
using the program SEDNTERP52.
RPAP3523–665 expression, puriﬁcation, and crystallization. The gene encoding
RPAP3523–665 fragment was cloned into the NdeI and BamHI site of the p3E
plasmid (home grown plasmid from University of Sussex). BL21 (DE3) E. coli cells
(F¯ ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 *lacI lacUV5-T7gene 1 ind1 sam7
nin5), NZYTech) were transformed with p3E plasmid containing RPAP3523–665.
The transformed cells were grown in LB media at 37 °C for 5 h followed by
induction with 1 mM IPTG. The cells were further grown for 15 h at 20 °C. Cells
were harvested using 5000×g for 10 min. The cell pellet was re-suspended in 20
mM HEPES pH 7.8, 140 mM NaCl, 0.5 mM TCEP, and sonicated at 4 °C. The cell
lysate was spun at 20,000 g for 1 h at 4 °C and the supernatant was used for the
GST afﬁnity chromatography. The puriﬁed GST-RPAP3523–665 protein was treated
with PreScission protease overnight at 4 °C to remove the GST-tag and the protein
was further puriﬁed by SEC.
Puriﬁed RPAP3523–665 protein was concentrated to 8 mgml−1 using 10k
MWCO viva-spin (Sartorius). The crystallization trials were set up using 0.2 μl
protein and 0.2 μl crystallization screen buffer using sitting drop method. The
crystallization trial trays were incubated at 14 °C. Small crystals appeared in 0.5 M
potassium thiocyanate, 0.1 M bis-tris propane pH 7.0 (well H6) of SaltRX crystal
screen (Hampton research Ltd) after 1 month of incubation. The crystals were ﬂash
frozen in liquid nitrogen using 30% glycerol as a cryo-protectant and the data were
collected at Diamond Light source, UK. Wavelength used was 0.9763 Å.
The data were processed using standard methodology, and programs of the
CCP4 suite53, Xia254, REFMAC55, BUSTER (https://sbgrid.org/software/titles/
buster), and COOT36, together with the ARCIMBOLDO software56
(Supplementary Table 4).
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Data availability. Data supporting the ﬁndings of this manuscript are available
from the corresponding authors upon reasonable request.
The EM maps have been deposited in EMDB and PDB: EMD-4289 (R2TP-
C3symmetry); EMD-4287 (R2TP-1RBD); EMD-4290 (R2TP-subgroup1); EMD-
4291 (R2TP-subgroup2); PDB 6FO1 (model of RUVBL1–RUVBL2–RBD with
1RBD), and PDB 6FM8 (crystal structure of RBD fragment).
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